Opko Health (OPK) Income from Continuing Operations (2010 - 2026)
Opko Health's (OPK) quarterly Income from Continuing Operations came in at 8416000.0 in Q2 2026, up 94.33% YoY from 4330768.46 in Q2 2025, and up 84.66% on a QoQ basis from 54846000.0 in Q1 2026.
Opko Health (OPK) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Opko Health (OPK) has 17 years of Income from Continuing Operations data on file, last reported at 8416000.0 in Q2 2026.
- Quarterly Income from Continuing Operations rose 94.33% year-over-year to 8416000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 37889000.0 (up 86.63% YoY) and the FY2025 annual result came in at 190672000.0, down 258.37% from the prior year.
- Income from Continuing Operations grew to 8416000.0 in Q2 2026, from 54846000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 24893000.0 in Q3 2024 to a low of 148441000.0 in Q2 2025.
- A 5-year average of 54105235.29 and a median of 66475000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations tumbled 528.96% — and 2024, when it jumped 129.48%.
- Tracing OPK's Income from Continuing Operations over 5 years: stood at 85207000.0 in 2022, then increased by 21.98% to 66475000.0 in 2023, then jumped by 137.45% to 24893000.0 in 2024, then sank by 84.98% to 3739000.0 in 2025, then slumped by 325.09% to 8416000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 8416000.0 (Q2 2026), 54846000.0 (Q1 2026), and 3739000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Opko Health | 993.18 Mn | 692.42 Mn | 80.02 Mn | -8.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.42 Mn |
| Mar 31, 2026 | -54.85 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Sep 30, 2025 | 21.63 Mn |
| Jun 30, 2025 | -148.44 Mn |
| Mar 31, 2025 | -67.60 Mn |
| Sep 30, 2024 | 24.89 Mn |
| Jun 30, 2024 | -92.14 Mn |
| Mar 31, 2024 | -81.83 Mn |
| Dec 31, 2023 | -66.48 Mn |
| Sep 30, 2023 | -84.45 Mn |
| Jun 30, 2023 | -19.60 Mn |
| Mar 31, 2023 | -18.23 Mn |
| Dec 31, 2022 | -85.21 Mn |
| Sep 30, 2022 | -86.05 Mn |
| Jun 30, 2022 | -101.38 Mn |
| Mar 31, 2022 | -55.38 Mn |
| Dec 31, 2021 | -73.31 Mn |
| Sep 30, 2021 | 28.79 Mn |
| Jun 30, 2021 | -16.12 Mn |